Guardian Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Buy |
|
|||||
|
2025
Q1 | $14.7M | Buy |
|
|||||
|
2024
Q4 | $18.2M | Buy |
|
|||||
|
2024
Q3 | $24.9M | Sell |
|
|||||
|
2024
Q2 | $30M | Sell |
|
|||||
|
2024
Q1 | $27.1M | Sell |
|
|||||
|
2023
Q4 | $21.9M | Sell |
|
|||||
|
2023
Q3 | $19.5M | Sell |
|
|||||
|
2023
Q2 | $20M | Sell |
|
|||||
|
2023
Q1 | $19.9M | Sell |
|
|||||
|
2022
Q4 | $17.1M | Sell |
|
|||||
|
2022
Q3 | $12.6M | Sell |
|
|||||
|
2022
Q2 | $14.2M | Buy |
|
|||||
|
2022
Q1 | $12.5M | Buy |
|
|||||
|
2021
Q4 | $12.6M | Sell |
|
|||||
|
2021
Q3 | $11M | Buy |
|
|||||
|
2021
Q2 | $8.42M | Buy |
|
|||||
|
2021
Q1 | $6.77M | Buy |
|
|||||
|
2020
Q4 | $6.39M | Sell |
|
|||||
|
2020
Q3 | $6.35M | Sell |
|
|||||
|
2020
Q2 | $6.19M | Buy |
|
|||||
|
2020
Q1 | $5.56M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $374K | Sell |
|
|||||
|
2018
Q3 | $13.3M | Buy |
|
|||||
|
2018
Q2 | $11.2M | Sell |
|
|||||
|
2018
Q1 | $12.6M | Buy |
|
|||||
|
2017
Q4 | $12M | Buy |
|
|||||
|
2017
Q3 | $9.45M | Buy |
|
|||||
|
2017
Q2 | $8.01M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $10.1M | Buy |
|
|||||
|
2015
Q3 | $7.57M | Buy |
|
|||||
|
2015
Q2 | $4.76M | Buy |
|
|||||
|
2015
Q1 | $3.64M | Sell |
|
|||||
|
2014
Q4 | $4.16M | Buy |
|
|||||
|
2014
Q3 | $2.82M | Sell |
|
|||||
|
2014
Q2 | $2.79M | Sell |
|
|||||
|
2014
Q1 | $2.81M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $834K | Sell |
|
|||||
|
2013
Q2 | $2.54M | Buy |
|